What is the recommended dosing for propranolol (beta-blocker) in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Propranolol Dosing in Adults

For hypertension in adults, start propranolol immediate-release at 80-160 mg daily divided into 2 doses, or propranolol long-acting at 80 mg once daily, with a usual maintenance dose of 120-160 mg daily and a maximum of 640 mg daily if needed. 1, 2

Dosing by Indication

Hypertension

  • Immediate-release formulation: 80-160 mg daily divided into 2 doses 1
  • Long-acting formulation: Start at 80 mg once daily, increase to 120-160 mg once daily for maintenance 2
  • Maximum dose may reach 640 mg daily in some patients 1, 2
  • Full antihypertensive response may take days to several weeks at any given dose 2

Angina Pectoris

  • Start at 80 mg long-acting once daily 2
  • Increase gradually at 3-7 day intervals until optimal response 2
  • Average optimal dose is 160 mg once daily 2
  • Maximum studied dose is 320 mg daily; safety beyond this is not established 2

Migraine Prophylaxis

  • Initial dose: 80 mg long-acting once daily 2
  • Usual effective range: 160-240 mg once daily 2
  • If no response after 4-6 weeks at maximum dose, discontinue with gradual taper 2

Hypertrophic Subaortic Stenosis

  • Usual dose: 80-160 mg long-acting once daily 2

Critical Pre-Treatment Assessment

Before initiating propranolol, screen for absolute contraindications including second or third-degree heart block, decompensated heart failure, asthma/obstructive airway disease, cardiogenic shock, and sinus node dysfunction without pacemaker. 3

  • Measure baseline heart rate and blood pressure 3
  • Perform cardiovascular examination with auscultation 3
  • Screen for history of bronchospasm, diabetes, and concurrent medications affecting cardiac conduction 3
  • ECG and echocardiogram are only needed in selected cases with cardiac concerns 3
  • Routine blood work (CBC, renal, liver, thyroid function) is not required in otherwise healthy adults 3

Monitoring During Treatment

  • Monitor for hypotension and bradycardia, especially during dose escalation 3
  • No routine vital sign monitoring required between appointments if patient is stable and asymptomatic 3
  • Watch for common adverse effects: fatigue, bradycardia, hypotension, dizziness, cold extremities, and potential worsening of heart failure 3

Important Safety Considerations

Never abruptly discontinue propranolol, especially after chronic use—taper gradually over several weeks to avoid rebound hypertension, tachycardia, or angina. 1, 3

  • Propranolol may mask symptoms of hypoglycemia in diabetic patients 3
  • Avoid routine combination with non-dihydropyridine calcium channel blockers (diltiazem, verapamil) due to increased risk of bradycardia and heart block 1, 3
  • Elderly patients may require lower doses due to altered pharmacokinetics 3

Formulation Considerations

  • Immediate-release propranolol requires twice-daily dosing (80-160 mg total daily dose divided) 1
  • Long-acting formulations allow once-daily dosing but are not simple mg-for-mg substitutes for immediate-release 2
  • When switching from immediate-release to extended-release, retitration may be necessary to maintain effectiveness, especially at the end of the 24-hour dosing interval 2

Relative Efficacy by Dose

Research demonstrates that relatively low doses (80-160 mg daily) induce most of the antihypertensive effect of propranolol, with minimal additional benefit at higher doses. 4 Complete cardiac beta-blockade may not be necessary for full hypotensive effect. 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Medication Transition from Flupentixol/Melitracen to Propranolol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antihypertensive effect of propranolol at rest and during exercise.

British journal of clinical pharmacology, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.